To investigate the hypothesis that intestinal colonization by differing kinds of carbapenemase-resistant Klebsiella pneumoniae (CR-Kp) results in diverse threats for BSI attributable to the same colonizing organism.aberrations that are refractory or intolerant to both equally chemoimmunotherapy and ibrutinib. Venetoclax as well as rituximab (VR) is